PLEASANTON, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced its
Board of Directors has approved a $500 million increase in the company’s share repurchase program. The share repurchase program now
totals $1 billion and has approximately $618.5 million of remaining availability with no expiration date.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is
dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business
units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing
a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is
committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health,
fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100
countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT: Kim Duncan Vice President, Investor Relations ir@cooperco.com
